Article
Moderna reins in 2023 COVID vaccine forecast, shares tumble
Rating:
0.0
Views:
43
Likes:
1
Library:
1
Moderna on Thursday said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 vaccines, and its shares slumped 8%.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value